• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化腹水综合征发生及持续存在中的淋巴失衡

Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis.

作者信息

Witte C L, Witte M H, Dumont A E

出版信息

Gastroenterology. 1980 May;78(5 Pt 1):1059-68.

PMID:7380179
Abstract

Despite extensive study, the pathogenesis of cirrhotic ascites and its relationship to salt and water retention and the hepatorenal syndrome remain unclear. This article reexamines the underlying disturbance in microcirculatory exchange of fluid and protein in the liver and digestive tract and specifically stresses that, in keeping with current interpretation of the Starling hypothesis, ascites appears when the driving force of elevated portal pressure overwhelms the "safety factors" of widened transmural colloid asmotic pressure gradient and accelerated regional lymph flow. In light of recent findings that enhancement of ascitic fluid returned to the bloodstream produces a natriuresis, diuresis, and amelioration of ascites, a "lymph imbalance" theory distinct from the "classic" and "overflow" theories is advanced. This theory proposes that a circulatory imbalance between the rate of fluid leaving and returning to the bloodstream (i.e., the relative rates of lymph formation and lymph absorption) is responsible for a maldistribution of extracellular fluid, which, in turn, stimulates renal salt and water retention, progression of ascites, and finally, the hepatorenal syndrome. Should compensatory factors suffice to prevent or reverse this lymph imbalance, the full cycle is not activated or, if already operating, is deactivated. Thus, portacaval shunt (by reducing the rate of lymph formation) or peritoneovenous shunt (by acting as a megalymphatic collateral to accelerate resorption as well as prevent sequestration of peritoneal fluid), both tend to restore the lymph balance and thereby suppress salt and water retention, correct functional oliguria, and ameliorate ascites.

摘要

尽管进行了广泛研究,但肝硬化腹水的发病机制及其与水钠潴留和肝肾综合征的关系仍不清楚。本文重新审视了肝脏和消化道中液体和蛋白质微循环交换的潜在紊乱,并特别强调,根据目前对斯塔林假说的解释,当门静脉压力升高的驱动力超过跨壁胶体渗透压梯度增宽和局部淋巴液流动加速的“安全因素”时,腹水就会出现。鉴于最近的研究发现,腹水回流入血液增加会导致利钠、利尿和腹水改善,本文提出了一种不同于“经典”和“溢流”理论的“淋巴失衡”理论。该理论认为,液体离开和回流入血液的速率之间的循环失衡(即淋巴生成和淋巴吸收的相对速率)导致细胞外液分布不均,进而刺激肾脏水钠潴留、腹水进展,最终导致肝肾综合征。如果代偿因素足以预防或逆转这种淋巴失衡,则整个循环不会被激活,或者如果已经在运作,则会被停用。因此,门腔分流术(通过降低淋巴生成速率)或腹腔静脉分流术(通过充当巨大淋巴管侧支来加速吸收并防止腹腔积液潴留)都倾向于恢复淋巴平衡,从而抑制水钠潴留,纠正功能性少尿,并改善腹水。

相似文献

1
Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis.肝硬化腹水综合征发生及持续存在中的淋巴失衡
Gastroenterology. 1980 May;78(5 Pt 1):1059-68.
2
Splanchnic circulatory and tissue fluid dynamics in portal hypertension.门静脉高压症中的内脏循环与组织液动力学
Fed Proc. 1983 Apr;42(6):1685-9.
3
Pathogenesis of ascites in cirrhosis and portal hypertension.肝硬化和门静脉高压症中腹水的发病机制。
Med Sci Monit. 2000 Jul-Aug;6(4):807-16.
4
Ascites formation in cirrhosis and its management.肝硬化腹水的形成及其管理。
Scand J Gastroenterol Suppl. 1970;7:9-15.
5
Fluid retention in cirrhosis: pathophysiology and management.肝硬化中的液体潴留:病理生理学与管理
QJM. 2008 Feb;101(2):71-85. doi: 10.1093/qjmed/hcm121. Epub 2008 Jan 9.
6
[Dynamics of ascitic fluid in decompensated cirrhosis].
Recenti Prog Med. 1999 Feb;90(2):94-9.
7
Cirrhotic ascites: pathogenesis and management.肝硬化腹水:发病机制与管理
Gastroenterologist. 1995 Mar;3(1):41-54.
8
Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.用于治疗顽固性肝硬化腹水的侧侧门腔分流术的实验、临床及代谢结果
J Am Coll Surg. 1997 Jun;184(6):557-70.
9
Pathophysiology of ascites formation.
Gastroenterol Clin North Am. 1992 Mar;21(1):215-35.
10
The role of lymphatics in the formation of ascites complicating schistosomal hepatic fibrosis.淋巴管在血吸虫性肝纤维化并发腹水形成中的作用。
Lymphology. 1976 Jun;9(2):43-6.

引用本文的文献

1
The interplay between lymphatic system and portal hypertension: a comprehensive review.淋巴系统与门静脉高压之间的相互作用:综述
Hepatol Int. 2025 Apr 3. doi: 10.1007/s12072-025-10815-5.
2
Modulation of lymphatic vessels in management of liver disease and complications.肝脏疾病及其并发症管理中淋巴管的调节作用
Clin Mol Hepatol. 2025 Apr;31(2):665-668. doi: 10.3350/cmh.2024.0793. Epub 2024 Oct 17.
3
Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites.胸导管裂孔作为托伐普坦治疗严重肝硬化腹水反应的最佳标志物。
Sci Rep. 2022 May 17;12(1):8124. doi: 10.1038/s41598-022-11889-z.
4
Case Report: Severe Edema and Marked Weight Gain Induced by Marginal Thiamine Deficiency in a Patient With Alcohol Dependency and Type 2 Diabetes Mellitus.病例报告:酒精依赖和2型糖尿病患者边缘性硫胺素缺乏导致严重水肿和显著体重增加
Front Nutr. 2021 Dec 15;8:675992. doi: 10.3389/fnut.2021.675992. eCollection 2021.
5
Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Refractory Transudative Chylothorax due to Liver Cirrhosis.经颈静脉肝内门体分流术(TIPS)治疗肝硬化所致难治性漏出性乳糜胸
Case Rep Med. 2020 Feb 7;2020:2581040. doi: 10.1155/2020/2581040. eCollection 2020.
6
Emerging Roles for Lymphatics in Chronic Liver Disease.淋巴管在慢性肝病中的新作用
Front Physiol. 2020 Jan 14;10:1579. doi: 10.3389/fphys.2019.01579. eCollection 2019.
7
Changes of Intestinal Functions in Liver Cirrhosis.肝硬化患者肠道功能的变化
Inflamm Intest Dis. 2016 Apr;1(1):24-40. doi: 10.1159/000444436. Epub 2016 Mar 8.
8
Ascites, refractory ascites and hyponatremia in cirrhosis.肝硬化中的腹水、顽固性腹水和低钠血症
Gastroenterol Rep (Oxf). 2017 May;5(2):104-112. doi: 10.1093/gastro/gox010. Epub 2017 Apr 24.
9
The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.肝淋巴血管系统:结构、功能、标志物与淋巴管生成
Cell Mol Gastroenterol Hepatol. 2016 Sep 14;2(6):733-749. doi: 10.1016/j.jcmgh.2016.09.002. eCollection 2016 Nov.
10
Budd-Chiari syndrome: etiology, pathogenesis and diagnosis.布加综合征:病因、发病机制与诊断
World J Gastroenterol. 2007 May 21;13(19):2693-6. doi: 10.3748/wjg.v13.i19.2693.